Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial

Jens Lundgren; Abdel Babiker; Fred Gordin; Sean Emery; Gerd Fätkenheuer; Jean-Michel Molina; Robin Wood; James D Neaton; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

doi:10.1111/hiv.12227

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

Jens Lundgren, Abdel Babiker, Fred Gordin, Sean Emery, Gerd Fätkenheuer, Jean-Michel Molina, Robin Wood, James D Neaton, INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

Department of Clinical Medicine

26 Citations (Scopus)

Original language	English
Journal	HIV Medicine
Volume	16
Issue number	Suppl 1
Pages (from-to)	1-9
Number of pages	9
ISSN	1464-2662
DOIs	https://doi.org/10.1111/hiv.12227
Publication status	Published - 1 Apr 2015

Keywords

Adult
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Cohort Studies
Female
HIV Infections
Humans
Male
Randomized Controlled Trials as Topic
Time Factors
Treatment Outcome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/hiv.12227

hiv.12227Final published version, 107 KB

Cite this

@article{a15c9b86cc5640b98aa302b2568825c5,

title = "Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial",

keywords = "Adult, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections, Humans, Male, Randomized Controlled Trials as Topic, Time Factors, Treatment Outcome",

author = "Jens Lundgren and Abdel Babiker and Fred Gordin and Sean Emery and Gerd F{\"a}tkenheuer and Jean-Michel Molina and Robin Wood and Neaton, {James D} and {INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group}",

year = "2015",

month = apr,

day = "1",

doi = "10.1111/hiv.12227",

language = "English",

volume = "16 ",

pages = "1--9",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Wiley-Blackwell",

number = "Suppl 1",

}

TY - JOUR

T1 - Why START?

T2 - Reflections that led to the conduct of this large long-term strategic HIV trial

AU - Lundgren, Jens

AU - Babiker, Abdel

AU - Gordin, Fred

AU - Emery, Sean

AU - Fätkenheuer, Gerd

AU - Molina, Jean-Michel

AU - Wood, Robin

AU - Neaton, James D

AU - INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

PY - 2015/4/1

Y1 - 2015/4/1

KW - Adult

KW - Anti-Retroviral Agents

KW - Antiretroviral Therapy, Highly Active

KW - CD4 Lymphocyte Count

KW - Cohort Studies

KW - Female

KW - HIV Infections

KW - Humans

KW - Male

KW - Randomized Controlled Trials as Topic

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1111/hiv.12227

DO - 10.1111/hiv.12227

M3 - Editorial

C2 - 25711317

SN - 1464-2662

VL - 16

SP - 1

EP - 9

JO - HIV Medicine

JF - HIV Medicine

IS - Suppl 1

ER -